baber/WOPTO huggingface dataset:
Patent CA-3140256-A1 (CA)
Inventor: SIENICKI MARCIN
IPC: G06Q30/02
Filed: 2020-06-03
Abstract: Live inventory management environment system and methods are disclosed. A shelf for items has bins each with an associated sensor. A processor receives a detection signal from the sensor which indicates placement or removal an item(s) from an associated bin. An entry device sends an entered request for placement or removal of items to the processor, and an indicator strip has lights which uniquely identify each one of the bins when lit. The processor has information relating to which bin each subset of lights is associated, and causes activation of a subset of lights associated with a bin of the item(s) in the request and records in memory a type of action, a timestamp and a quantity of the item(s) placed or removed from the bin having the subset of lights lit and indicated in the detection signal subsequently received from the sensor of the associated bin.
Patent CA-3141980-A1 (CA)
Title: Couteau abrasif et methode de coupe dans un rail d'une voie ferree
Inventor: KAMML DIETER LUDWIG
IPC: B24B41/00
Filed: 2020-05-06
Abstract: Un couteau abrasif pour couper un rail de voie ferrée comprend un moteur pour entraîner un porte-disque de coupe en rotation. Un disque de coupe est attaché au porte-disque de coupe au moyen d'au moins un élément de serrage. Le moteur est directement couplé au porte-disque de coupe et présente une étendue transversale maximale au plus égale au diamètre d'au moins un élément de serrage. Le moteur comprend un moteur d'entraînement électrique à densité de puissance de Pspez = 0,5 kW/kg. Le couteau abrasif permet une coupe complète fiable, efficace, facile et faible d'entretien d'un rail de voie ferrée.
Patent CA-3142963-A1 (CA)
Inventor: TIAN HONGQI
IPC: C07C319/06
Filed: 2020-06-13
Abstract: L'invention concerne l'utilisation de composés aminothiol en tant qu'agents de protection des nerfs cérébraux ou du coeur, en particulier dans la prévention et/ou le traitement de maladies cardiovasculaires et cérébrovasculaires, telles que des lésions et des attaques cardiaques et cérébrales d'ischémie/reperfusion.
Patent CA-3144081-A1 (CA)
Title: Utilisation de compositions therapeutiques comprenant du sang de cordon ombilical pour le traitement d'une maladie cardiovasculaire ou d'une lesion cerebrale
Inventor: WANG JONAS
IPC: A61K35/545
Filed: 2020-08-20
Abstract: La présente invention concerne l'utilisation d'une composition thérapeutique contenant du sang de cordon ombilical pour traiter ou soulager une maladie cardiovasculaire ou un traumatisme cérébral chez un sujet en ayant besoin. Le sang de cordon ombilical comprend du sang de cordon ombilical appauvri en plasma ou du sang de cordon ombilical partiellement appauvri en globules rouges. L'utilisation décrite comprend également l'utilisation d'une composition perméabilisante à barrière hémato-encéphalique.
Patent CA-3144333-A1 (CA)
Title: Micellar nanoparticles and uses thereof
Inventor: RYU JIN-HYEOB
IPC: A61K47/60
Filed: 2020-06-26
Abstract: The present disclosure includes cationic carrier units comprising (i) a water soluble polymer, (ii) a positively charged carrier, and (iii) an adjuvant moiety, wherein when the cationic carrier unit is mixed with an anionic payload (e.g., an antisense oligonucleotide) that electrostatically interacts with the cationic carrier unit, the resulting composition self-organizes into a micelle encapsulating the anionic payload in its core. The cationic carrier units can also comprise a tissue specific targeting moiety, which would be displayed on the surface of the micelle. The disclosure also includes micelles comprising the cationic carrier units of the disclosure, methods of manufacture of cationic carrier units and micelles, pharmaceutical compositions comprising the micelles, and also methods of treating diseases or conditions comprising administering the micelles to a subject in need thereof.
Patent CA-3151696-A1 (CA)
Inventor: CAI ZHE
IPC: C07D498/04
Filed: 2020-09-18
Abstract: A crystal form of a hepatitis B surface antigen inhibitor and a preparation method, and an application of the crystal form in the preparation of the hepatitis B surface antigen inhibitor.
Patent CA-3152766-A1 (CA)
Title: Detection of abnormal conditions on a wind turbine generator
Inventor: LUBKER POUL ANKER SKAARUP
IPC: F03D7/00
Filed: 2020-08-21
Abstract: Disclosed is a method of detecting abnormal conditions, e.g. of a blade or a rotor, on a wind turbine generator. Also disclosed is a system for detecting abnormal conditions, e.g. of a blade or rotor on a wind turbine generator.
Patent CA-3153253-A1 (CA)
Inventor: EITSCHBERGER CHRISTIAN
IPC: E21B17/02
Filed: 2022-03-23
Abstract: Disclosed embodiments relate to weight modules for use in a wellbore tool string. In some embodiments, the weight module may comprise a conductive body, extending in an axial direction, and an insulating cover. The conductive body may be configured to fit within a hollow interior of a weight module housing, and the insulating cover may be configured to electrically isolate the conductive body from the weight module housing. In some embodiments, the conductive body may have a first contact portion, provided at a first end of the conductive body, and a second contact portion, provided at a second end of the conductive body, with the first contact portion in electrical communication with the second contact portion through the conductive body.
Patent CA-3153636-A1 (CA)
Title: Anti-cd47 and anti-cd20 based treatment of blood cancer
Inventor: CHAO MARK PING
IPC: A61P39/00
Filed: 2020-10-29
Abstract: Methods are provided herein for determining the eligibility of a subject to receive a treatment based on a presence or absence of B- cells in the subject, and subsequently treating the eligible subject with the anti-CD47 treatment in combination with an additional agent such as an anti-CD20 antibody.
Patent CA-3153888-A1 (CA)
Title: Polymorphes d'avapritinib et leurs procedes de preparation
Inventor: BONNAUD THIERRY
IPC: C07D487/04
Filed: 2020-10-23
Abstract: La présente invention concerne des formes cristallines et non cristallines d'avapritinib, des procédés pour leur préparation, et des compositions pharmaceutiques contenant les formes cristallines ou non cristallines.
Patent CA-3162484-A1 (CA)
Title: Blister pack and blister pack holder
Inventor: YAVETS-CHEN YEHUDA
IPC: B65B47/04
Filed: 2021-01-13
Abstract: A blister pack may include a containing body with an opening; and a lid sealed over the opening and provided with a weakening pattern, wherein a width of the lid at the weakening pattern is thinner that a width of the lid elsewhere, and wherein the lid is configured to burst at the weakening pattern when the blister pack is subjected to pressure, so as to allow liquid content inside the containing body to be discharged out of the blister pack through the burst weakening pattern. A blister pack holder is also disclosed.
Patent CA-3162977-A1 (CA)
Inventor: MARTHALER MICHAEL
IPC: G06N10/00
Filed: 2021-04-12
Abstract: L'invention concerne un procédé (1) pour simuler un système de spins bruité au moyen d'un ordinateur quantique, dans lequel procédé un système de spins réel (3) est mis en correspondance avec un système de spins quantiques abstrait (4) et au moins un paramètre physique à déterminer est mis en correspondance avec le système de spins quantiques abstrait (4). Le procédé est caractérisé en ce qu'un algorithme de simulation est créé pour le système de spins quantiques abstrait (4) et les taux de décohence et les opérateurs de couplage correspondants de tous les bits quantiques disponibles (5) d'un ordinateur quantique (6) sont déterminés, et en ce que les taux de décohence effectifs des spins (2) du système de spins quantiques abstrait (4) sont déterminés et les taux de décohence effectifs des spins (2) du système de spins quantiques abstrait (4) sont cartographiés au moyen des spins (2) et des taux de décohence associés des bits quantiques (5) de l'ordinateur quantique (6) de manière à simuler ensuite le système de spins quantiques abstrait (4) sur un ordinateur quantique (6) et à déterminer le ou les paramètres physiques du système de spins quantiques abstrait (4) qui doivent être déterminés.
Patent CA-3164624-A1 (CA)
Inventor: GORRELL MATTHEW W
IPC: B01D46/02
Filed: 2020-12-10
Abstract: L'invention concerne des milieux filtrants. En particulier, un milieu filtrant comprend un côté admission, un côté échappement et une pluralité de fibres réparties dans le milieu filtrant. Les fibres ont une pluralité de deniers, et des fibres disposées à proximité du côté d'admission ont un premier denier et des fibres disposées à proximité du côté d'échappement ont un second denier. Le premier denier est plus grand que le second denier.
Patent CA-3165275-A1 (CA)
Inventor: JOLY-TONETTI NICOLAS
IPC: G01N33/50
Filed: 2020-10-30
Abstract: An epidermal tridimensional model exhibiting differentiating keratinocytes in a reconstituted stratum corneum model is disclosed. The model, which contains a cancer therapeutic at an amount effective to simulate chronic drug exposure, can be used to evaluate the potential of cancer therapeutics to produce skin related side effects. The method can also be used to evaluate the efficacy of a composition in reducing the effects of cancer therapeutics on skin.
Patent CA-3168667-A1 (CA)
Inventor: WERTZ CHRISTIAN F
IPC: A61K9/14
Filed: 2021-01-22
Abstract: Dispersions solides amorphes et compositions pharmaceutiques dasatinib inhibiteur de protéine kinase. Les compositions pharmaceutiques peuvent être utilisées dans des procédés de traitement d'un trouble prolifératif tel que le cancer, ou dans des procédés d'administration de dasatinib à des patients que le patient reçoive parallèlement un agent de réduction de l'acide gastrique ou non, ou que le patient présente un pH gastrique élevé ou non. Les compositions conviennent particulièrement aux patients atteints d'achlorhydrie ou d'hypochlorhydrie, ou d'une infection par Helicobacter pylori.
Patent CA-3168881-A1 (CA)
Inventor: DODGE JAMES
IPC: A61P3/00
Filed: 2007-02-08
Abstract: An agent that is suitable for delivery to a patient's brain, for use in a method comprising administering the agent to the patient via a lateral ventricle of the brain at a rate such that the administration of a single dose consumes more than four hours, wherein the administration is performed until said agent is detectable in the serum of the patient, and wherein the agent is an enzyme that is deficient in a lysosomal storage disease.
Patent CA-3169076-A1 (CA)
Inventor: MANGIAT STEPHEN VINCENT
IPC: H04N13/332
Filed: 2016-09-13
Abstract: Examples of wearable devices that can present to a user of the display device an audible or visual representation of an audio file comprising a plurality of stem tracks that represent different audio content of the audio file are described. Systems and methods are described that deterrnine the pose of the user; generate, based on the pose of the user, an audio mix of at least one of the plurality of stem tracks of the audio file;  generate, based on the pose of the user and the audio mix, a visualization of the audio mix;  communicate an audio signal representative of the audio mix to the speaker; and communicate a visual signal representative of the visualization of the audio mix to the display.
Patent CA-3169207-A1 (CA)
Inventor: GRILL WARREN M
IPC: A61N1/36
Filed: 2012-10-11
Abstract: Systems and methods for stimulation of neurological tissue and generation stimulation trains with temporal patterns of stimulation, in which the interval between electrical pulses (the inter-pulse intervals) changes or varies over time. The features of the stimulation trains may be selected and arranged algorithmically to by clinical trial. These stimulation trains are generated to target a specific neurological disorder, by arranging sets of features which reduce symptoms of that neurological disorder into a pattern which is effective at reducing those symptoms while maintaining or reducing power consumption versus regular stimulation signals. Compared to conventional continuous, high rate pulse trains having regular (i.e., constant) inter-pulse intervals, the non-regular (i.e., not constant) pulse patterns or trains that embody features of the invention provide increased efficacy and/or a lower than average frequency.
Patent CA-3171437-A1 (CA)
Inventor: MANDELIK DANIEL
IPC: A23J3/22
Filed: 2021-03-24
Abstract: The present disclosure provides a single or a set of packed protein unit for use in fabrication of a meat analogue product, the packed protein unit comprises at least one elongated texturized protein strip held, in an organized spatial configuration, by or within a retaining element, the at least one elongated texturized protein strip being defined by a longitudinal axis and a cross sectional area taken perpendicular to the longitudinal axis; wherein at least one dimension of said cross sectional area is equal or less than 10mm and said longitudinal axis has a dimension of at least 100mm. Also disclosed herein is a method of fabricating a meat analogue product making use of one or more packed protein units disclosed herein.
Patent CA-3171817-A1 (CA)
Title: Appareil d'extraction et procede d'extraction pour un milieu de fermentation
Inventor: LUNG GERHARD
IPC: C05F17/986
Filed: 2021-02-18
Abstract: Un appareil d'extraction pour un milieu de fermentation comprend une chambre d'extraction conçue pour recevoir un milieu de fermentation ainsi qu'une section inférieure et une section supérieure au-dessus de la section inférieure et également un moyen d'introduction conçu pour introduire au moins un gaz et un liquide dans la partie inférieure de la chambre d'extraction ainsi qu'une ouverture d'évacuation qui est agencée dans la partie supérieure de la chambre d'extraction et qui est conçue pour évacuer un liquide d'extraction chargé de micro-organismes de la chambre d'extraction.
Patent CA-3172171-A1 (CA)
Inventor: BARTSEVICH VICTOR
IPC: C12N9/22
Filed: 2021-05-11
Abstract: L'invention concerne des méganucléases recombinantes conçues pour se lier à et cliver une séquence de reconnaissance présente dans un allèle RHO P23H mutant. L'invention concerne en outre l'utilisation de telles méganucléases recombinantes dans un procédé de traitement de la rétinite pigmentaire, l'allèle RHO P23H mutant étant préférentiellement ciblé, clivé et inactivé.
Patent CA-3175193-A1 (CA)
Inventor: REYNOLDS DOMINIC
IPC: A61P25/28
Filed: 2021-04-08
Abstract: La présente invention concerne des composés et des compositions associées qui, entre autres, modulent l'épissage d'acide nucléique, par exemple l'épissage d'un pré-ARNm, ainsi que des procédés d'utilisation de ceux-ci.
Patent CA-3179096-A1 (CA)
Inventor: CRISMANN SEBASTIANO
IPC: A47K5/12
Filed: 2020-05-20
Abstract: An adaptor assembly for use in a dispenser for a replaceable fluid container comprising a fluid reservoir and a fluid pump. The adapter assembly is used in conjunction with the dispenser to allow a use of a fluid container having a pump being actuated by laterally compressing it. The adaptor assembly comprises an actuation part being movable, when mounted in the dispenser, and comprises a first contact surface for abutting against the user actuator and a second contact surface for abutting against the pump. The adaptor assembly also comprises a first connecting support for removably connecting the actuation part to the dispenser and/or the fluid dispensing package mounted in the compartment. A fluid dispensing system including the adaptor assembly is also disclosed.
Patent CA-3179163-A1 (CA)
Inventor: BUCK RACHAEL
IPC: A23L33/00
Filed: 2015-04-03
Abstract: A method for enhancing an individual's mucosal innate immune response to pathogens is disclosed. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes about 0.05 to about 0.5 mg/mL 2'-fucosyllactose (2'-FL), about 0.05 to about 0.5 mg/mL lacto-N- neotetraose (LNnT), or a combination of both. Also disclosed is a method for enhancing an individual's mucosal innate immune detection of pathogens. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes a neutral human milk oligosaccharide.
Patent CA-3179814-A1 (CA)
Title: Methods of synthesizing farnesyl dibenzodiazepinones
Inventor: KIERNAN BERNARD MATTHEW
IPC: A61K31/5513
Filed: 2021-05-28
Abstract: The present invention is directed to synthetic means for producing farnesyl dibenzodiazepinone compounds, including AMO-01.
Patent CA-3182599-A1 (CA)
Title: Connector assembly
Inventor: STAUFFER FLURIN
IPC: B32B5/02
Filed: 2021-06-14
Abstract: The invention relates to a connector assembly, a seam tape, a garment and a method to produce a connector assembly.
Patent CA-3184270-A1 (CA)
Title: Methods and systems for quantitative detection of antibodies
Inventor: CHUN KELLY Y
IPC: G01N33/96
Filed: 2021-05-19
Abstract: The present disclosure relates to methods, systems, kits, and computer-program products for the quantification of antibodies. In an embodiment of the disclosure, the method comprises generating a standard curve and subsequently utilizing the standard curve to quantitate an antibody of interest. Also disclosed are systems, kits, and computer-program products for the quantitative detection of an antibody of interest in a sample using the methods described herein. In certain embodiments, the standard curve is developed using an immunoglobulin (e.g., IgG) that does not specifically recognize the antigen(s) recognized by the antibody of interest but is of the same immunoglobulin class as the antibody of interest (IgG). In this way, an applicable standard curve may be generated for various isolates of the antibody of interest.
Patent CA-3184292-A1 (CA)
Title: Crosslinked polymer modified asphalt compositions and methods of making and using thereof
Inventor: CLOPOTEL CRISTIAN S
IPC: C08K3/06
Filed: 2022-12-16
Abstract: Compositions and methods for the production of crosslinked polymer modified asphalt containing renewable products, such as ester bottoms or byproducts of soy oil or corn oil. Such compositions and methods may be used to reduce fire and explosion hazards associated with sulfur in preparation of crosslinked polymer modified asphalt.
Patent CA-3184849-A1 (CA)
Inventor: KUNZE MARTIN
IPC: G06K19/06
Filed: 2021-02-17
Abstract: The invention relates to a method for storage of information and to an information storage medium with increased storage density by mulit-bit coding.
Patent CA-3187782-A1 (CA)
Title: Extended reality-based user interface add-on, system and method for reviewing 3d or 4d medical image data
Inventor: SCHRECKENBERG MARCUS
IPC: G06F3/01
Filed: 2021-06-16
Abstract: The invention relates to a system (1) for reviewing 3D or 4D medical image data (2), the system (1) comprising (a) a medical review application (MRA) (4) comprising a processing module (6) configured to process a 3D or 4D dataset (2) to generate 3D content (8), and a 2D user interface (16); wherein the 2D user interface (16) is configured to display the 3D content (8) and to allow a user (30) to generate user input (18) commands; (b) an extended reality (XR)-based user interface add-on (XRA) (100); and (c) a data exchange channel (10), the data exchange channel (10) being configured to interface the processing module (6) with the XRA (100); wherein the XRA (100) is configured to interpret and process the 3D content (8) and convert it to XR content displayable to the user (30) in an XR environment (48); wherein the XR environment (48) is configured to allow a user to generate user input (18) events, and the XRA (100) is configured to process the user input (18) events and convert them to user input (18) commands readable by the MRA (4). The invention also relates to an extended reality -based user interface add-on (100), a related method for analysing a 3D or 4D dataset (2), and a related computer program.
Patent CA-3187865-A1 (CA)
Title: Localization system and method
Inventor: WILLIAMS MALCOLM NEWTON
IPC: G01S5/00
Filed: 2021-08-05
Abstract: A system comprises a plurality of first computing devices, wherein each first computing device is wearable by a user or is affixed to an asset within an environment and configured to generate and transmit a message; and a plurality of second computing devices installed within the environment, wherein a portion of the plurality of second computing devices are configured to detect at least one of the plurality of first computing devices, receive messages transmitted by a detected first computing device, and timestamp the messages before transmitting the messages to a computing server system. The computing server system is configured to determine at least a location of the detected first computing device based at least upon the messages received from the portion of the plurality of second computing devices.
Patent CA-3188170-A1 (CA)
Title: Association de vaccin contre une infection par le virus respiratoire syncytial
Inventor: CALLENDRET BENOIT C S
IPC: A61K39/12
Filed: 2021-06-29
Abstract: L'invention concerne des méthodes d'induction sûre d'une réponse immunitaire protectrice contre le virus respiratoire syncytial (VRS) et des méthodes de prévention d'une infection et/ou d'une réplication du VRS chez des sujets humains. Les méthodes consistent à administrer aux sujets (a) une quantité efficace d'un vecteur adénoviral codant pour une protéine F recombinée du VRS qui est stabilisée dans une conformation de préfusion, et (b) une quantité efficace d'une protéine F du VRS qui est stabilisée dans une conformation de préfusion.
Patent CA-3188858-A1 (CA)
Title: Cartomizer for an aerosol generating device with combined electrical and magnetic contacts
Inventor: LOVEDAY PETER
IPC: A24F40/40
Filed: 2021-09-01
Abstract: The present invention relates to a cartomizer 1 for an aerosol generating device 100, in particular an electronic cigarette or vaporizer, the cartomizer including: a first end 1A configured to engage with a control and power supply device 101, in particular of the aerosol generating device 100, and a second end 1B having a vapor outlet; the cartomizer 1 further including: a container 10 for holding at least one reservoir 11 configured to contain vaporizable material, a vaporizing unit 20 comprising an electrical heating element 21 and a liquid transport element 22, wherein the liquid transport element 22 is arranged to deliver vaporizable material or liquid from the at least one reservoir 11 to the heating element 21, a bottom holder 12 and a pair of electrodes 13A, 13B held by the bottom holder 12 at the first end 1A of the cartomizer 1, wherein the pair of electrodes 13A, 13B are made of a ferrous or ferro- magnetic material and are configured to extend transversally at the bottom holder 12 so that each electrode 13A, 13B forms a first portion of contact 14A with an electrical contact 102 of the control and power supply device 101 and a second portion of contact 14B adjacent the first portion of contact 14A to engage with a magnetic element 103 of the control and power device 101.
Patent CA-3190534-A1 (CA)
Inventor: GAFFAR ABDUL
IPC: A61K31/14
Filed: 2020-10-15
Abstract: L'invention concerne une composition antivirale contenant un agent antiviral cationique (agent cationique) et un sel de cuivre pour empêcher, réguler ou traiter des infections virales chez un mammifère, en particulier dans la zone nasopharyngée et la gorge chez les êtres humains et les animaux, ainsi qu'un procédé de prévention, de lutte ou de traitement d'infections virales chez un mammifère l'utilisant.